Skip to main content
. 2017 Jun 5;135(23):2227–2236. doi: 10.1161/CIRCULATIONAHA.116.026493

Figure 2.

Figure 2.

Freedom from clinically driven target lesion revascularization (CD-TLR) by Kaplan-Meier was significantly higher in the drug-coated balloon (DCB) group than the percutaneous transluminal angioplasty (PTA) group (P=0.010 by log-rank test; 94.8% vs 85.3% at day 365). Bars represent 95% confidence intervals.